Search for Clinical Trial Results
Primary Biliary Cholangitis - 29 Studies Found
Status | Study |
Recruiting |
Study Name: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis (PBC) Date: 2017-03-28 Interventions:
|
Recruiting |
Study Name: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis Date: 2017-03-24 Interventions:
|
Not yet recruiting |
Study Name: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis Condition: Primary Biliary Cholangitis Date: 2017-05-11 Interventions: Drug: APD334 APD334 active treatment for 24 weeks. O |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis Condition: Primary Biliary Cholangitis Date: 2016-06-13 Interventions:
|
Recruiting |
Study Name: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) Condition: Primary Biliary Cirrhosis Date: 2016-11-02 Interventions:
|
Recruiting |
Study Name: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients Condition: Primary Biliary Cholangitis Date: 2015-08-04 Interventions:
|
Active, not recruiting |
Study Name: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis Condition: Primary Biliary Cirrhosis Date: 2015-12-19 |
Not yet recruiting |
Study Name: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS) Condition: Primary Biliary Cirrhosis Date: 2017-04-10 Interventions:
|
Completed |
Study Name: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2006-08-15 Interventions: Drug: rituximab rituximab 1000 mg IV day 1 and 15, given over 5 - 6 hours |
Completed |
Study Name: Moexipril for Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2007-12-22 Interventions: Drug: Moexipril Moexipril was given at a starting dose of 7.5 mg daily for 1 week to all enrolled patien |